So proud of my friend and co resident @RoshalP who presented work examining genomic predictors of classical leptomeningeal and nodular leptomeningeal disease @ASCO 🧠 Mentored by Dr @Luke_Pike_MD @pike_lab

☢️Those who conduct MDT trials - how do you evaluate response? I use a "modified RECIST", b/c all forms of RECIST still not adequate for local therapy. Time to develop our own? @ChadTangMD @Mat_Guc @piet_ost @_ShankarSiva @DrOlsonOncology @fifimcdrmh @IyengarPuneeth @fifimcdrmh

Congratulations to Dr. Martin Weiser, who has been selected to serve serve as the next Chair of the Department of Surgery at MSK. Dr. Weiser currently holds the Stuart H.Q. Quan Chair in Colorectal Surgery, is a world-renowned academic colorectal surgeon, and has held a number of important leadership roles in his 25 years on the faculty at MSK, including serving for the past 10 months as the Acting Department Chair. Join us in welcoming Dr. Weiser to the role of Chair of the Department of Surgery by commenting below. 👏

🧬 Can tumor genomics be used to personalize radiation dose? Grateful to present results from our phase II trial on dose de-escalated radiation therapy for ATM altered tumors at #ASCO2026 Great to see ☢️ #Radiation in the early-phase #PrecisionOncology space!

I love the boldness of this study. Big fan!

Amen to that! This is worth getting to SOC. All we need is a blood biomarker or something other than FMISO so it can be applied widely @xrtGenomics , hurry up and come up with it! 🙃

Join MSK radiation oncologist Dr. Christopher Barker at #ASCO26 as he presents results from the phase II RAMPART trial evaluating response-adapted definitive radiotherapy and cemiplimab immunotherapy for locally advanced, unresectable cutaneous squamous cell carcinoma. 🕒 Monday, June 1 | 9:24 a.m. CDT Learn more: bit.ly/4fdLpOP

Proud of @MilitSPatel, who presented our work using #machine #learning to elucidate country specific drivers of global #cancer outcomes @ASCO #ASCO2026 Full paper in @Annals_Oncology 🔗 annalsofoncology.org/article…

75% of patients received 30 Gy with FMISO PET based de-escalation for HPV-associated OPSCC. 30 Gy. Need the randomized data but hard to believe this won’t be the way. Incredible!

Wonderful to see @DrPaulNguyen at @ASCO with members of our research group 🤩 Thank you Dr Nguyen for your example and continued mentorship for so many!

Join MSK radiation oncologist Dr. Nancy Lee (@imrtlee) at #ASCO26 for a clinical science symposium on FMISO PET-guided radiation dose de-escalation in HPV-associated oropharyngeal cancer. 🕒 Sunday, May 31 | 10:09 a.m. CDT Learn more: bit.ly/4u5Obta

Today at #ASCO26: MSK radiation oncologist Dr. Nancy Lee (@imrtlee) shared long-term results showing that many patients with HPV-positive #oropharyngeal cancer were able to receive lower-dose radiation while maintaining durable outcomes and experiencing fewer side effects.

Now we have PARTIQoL and COMPPARE….message is quite clear as to if there is any benefit of protons for localized prostate cancer. @DrSpratticus @seanmmcbride @TylerSbrt

Thrilled to be at @ASCO with many members of our research team, Collaborative Oncology Research Group International (CORGI 🐕) So proud of @MilitSPatel for THREE posters on #global #cancer systems today More to come!

Congratulations to MSK breast medical oncologist @jhaveri_komal on becoming a #FASCO inductee at #ASCO26! 🎉

New findings from MSK researchers that will be presented at #ASCO26 this weekend found that carefully selected patients with HPV-positive #throatcancer can receive significantly less radiation while maintaining excellent outcomes. An analysis of 430 patients showed a 97% five-year overall survival rate, even among patients who received less radiation. “This has been an absolute game-changer for treating certain people with throat cancers caused by HPV,” says MSK radiation oncologist @imrtlee. “The difference in toxicity is dramatic.” @ASCO Learn more: bit.ly/49tCmWi

Many thanks to Prof. Patrick Sheahan (@SheahanPatrick) and the Head and Neck Society for the generous invitation to give a keynote at their 5th Annual Meeting. Everything from the outstanding science to the amazing speakers and genuine multidisciplinary exchange to the beautiful venue (@LyrathEstate) could not have been better! Among a list of many distinguished speakers and attendees, it was wonderful to get the chance to reconnect with colleagues who also happen to be true leaders in the field like Dr. Nancy Lee (@imrtlee), Dr. mark zafereo (@MarkZafereoMD), Prof. Andreas Dietz (@UKL_Leipzig), and Prof. Giovanni Succo as well as meet some really outstanding oncologists and leaders like Prof. Shreerang Bhide (@royalmarsdenNHS) and Dr. Terry Day (@SarahCannonDocs). Thanks again and congratulations to Dr. Sheahan and the IHNS for an amazing meeting!

🚨 Anthropic just showed a 27-minute workshop on how to actually do prompts for Claude. Taught by the people who built it. Free. No registration. No paywall. I've seen $300 courses that don't cover what they teach in the first 8 minutes. Watch it and bookmark it now.

On paper, protons have a place in reirradiation. But in reality, the whole reirradiation space is built on a house of cards with EQD2 conversions and heterogeneous fractionation schemes. The truth is, we don't really know.

The authors of a new Perspective argue that clinicians are rightly expected to disclose their gaps in knowledge or their inability to forecast an outcome. Yet emerging AI tools often cannot, or will not, do the same. Read the Perspective by @AndreaSikora, PharmD, MSCR, Leo A. Celi, MD, MPH, and Raja-Elie E. Abdulnour, MD (@BageLeMage): nej.md/4fgdg0D